Anaprox ds and Head injury - a phase IV clinical study of FDA data

Summary:

Head injury is reported as a side effect among people who take Anaprox ds (naproxen sodium), especially for people who are female, 20-29 old, also take Ondansetron, and have Cataplexy.

The phase IV clinical study analyzes which people have Head injury when taking Anaprox ds. It is created by eHealthMe based on reports of 247 people who have side effects when taking Anaprox ds from the FDA, and is updated regularly.

What is Anaprox ds?

Anaprox ds has active ingredients of naproxen sodium. eHealthMe is studying from 265 Anaprox ds users. Check the latest studies of Anaprox ds.

What is Head injury?

Head injury is found to be associated with 2,628 drugs and 3,248 conditions by eHealthMe. Check the latest studies of Head injury.

On Jul, 13, 2026

247 people reported to have side effects when taking Anaprox ds.
Among them, 11 people (4.45%) have Head injury.

Among these 11 people:

What is the gender of people who have Head injury when taking Anaprox ds? *

female: 100 %
male: 0.0 %

What is the age of people who have Head injury when taking Anaprox ds? *

What are other drugs people take besides Anaprox ds? *

What are other side effects people have besides Head injury? *

Stress And Anxiety: 10 people, 90.91%
Headache (pain in head): 8 people, 72.73%
Memory Loss: 7 people, 63.64%
Pain: 7 people, 63.64%
Concussion (short loss of normal brain function in response to a head injury): 7 people, 63.64%
Post Concussion Syndrome: 6 people, 54.55%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 6 people, 54.55%
Victim Of Sexual Abuse: 4 people, 36.36%
Suicidal Ideation: 4 people, 36.36%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 27.27%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 72.73%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 72.73%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 3 people, 27.27%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 27.27%
Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 1 person, 9.09%
Urinary Tract Infection: 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Anaprox ds and have Head injury?

- Check whether Head injury is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anaprox ds:

Anaprox ds (265 reports)

Head injury treatments and more:

Head injury (160,560 reports)

Browse all side effects of Anaprox ds:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Head injury:

Head injury (2,628 drugs)

Browse all the conditions that are associated with Head injury:

Head injury (3,248 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen sodium (the active ingredients of Anaprox ds) and Anaprox ds (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.